nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—ABCC6—Dactinomycin—ocular cancer	0.617	0.752	CbGbCtD
Teniposide—ABCG2—Dactinomycin—ocular cancer	0.122	0.148	CbGbCtD
Teniposide—ABCG2—Carboplatin—ocular cancer	0.0818	0.0998	CbGbCtD
Teniposide—Extravasation—Carboplatin—ocular cancer	0.00264	0.134	CcSEcCtD
Teniposide—Phlebitis—Carboplatin—ocular cancer	0.00194	0.0984	CcSEcCtD
Teniposide—Raised liver function tests—Dactinomycin—ocular cancer	0.00185	0.0939	CcSEcCtD
Teniposide—Myelosuppression—Dactinomycin—ocular cancer	0.00182	0.0924	CcSEcCtD
Teniposide—Extravasation—Dactinomycin—ocular cancer	0.00098	0.0497	CcSEcCtD
Teniposide—Infection—Carboplatin—ocular cancer	0.000816	0.0414	CcSEcCtD
Teniposide—Sepsis—Dactinomycin—ocular cancer	0.000742	0.0376	CcSEcCtD
Teniposide—Phlebitis—Dactinomycin—ocular cancer	0.00072	0.0365	CcSEcCtD
Teniposide—Body temperature increased—Carboplatin—ocular cancer	0.000649	0.0329	CcSEcCtD
Teniposide—NCOA3—Retinoic acid receptors-mediated signaling—AKT1—ocular cancer	0.000639	0.00398	CbGpPWpGaD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.000626	0.0039	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000621	0.00387	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.000615	0.00383	CbGpPWpGaD
Teniposide—NCOA1—Notch-mediated HES/HEY network—EP300—ocular cancer	0.00061	0.00381	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.000604	0.00377	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.000601	0.00375	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.000599	0.00373	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.000577	0.0036	CbGpPWpGaD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.000577	0.00359	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000576	0.00359	CbGpPWpGaD
Teniposide—Liver function test abnormal—Dactinomycin—ocular cancer	0.000573	0.0291	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—E2F1—ocular cancer	0.000566	0.00353	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000565	0.00352	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—E2F1—ocular cancer	0.000558	0.00348	CbGpPWpGaD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000556	0.00347	CbGpPWpGaD
Teniposide—NCOA1—Regulation of Androgen receptor activity—EP300—ocular cancer	0.000555	0.00346	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—MDM2—ocular cancer	0.000552	0.00344	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—E2F5—ocular cancer	0.000551	0.00343	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.000545	0.0034	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00054	0.00337	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—E2F4—ocular cancer	0.00054	0.00336	CbGpPWpGaD
Teniposide—NCOA1—Circadian Clock—EP300—ocular cancer	0.000538	0.00336	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—RB1—ocular cancer	0.000536	0.00334	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—RBL1—ocular cancer	0.000529	0.0033	CbGpPWpGaD
Teniposide—NCOA1—Retinoic acid receptors-mediated signaling—AKT1—ocular cancer	0.000528	0.00329	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.000518	0.00323	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.000516	0.00322	CbGpPWpGaD
Teniposide—Pancytopenia—Dactinomycin—ocular cancer	0.000509	0.0258	CcSEcCtD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.000502	0.00313	CbGpPWpGaD
Teniposide—Neutropenia—Dactinomycin—ocular cancer	0.000502	0.0254	CcSEcCtD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—EP300—ocular cancer	0.000497	0.0031	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.000496	0.00309	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.000488	0.00304	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.000488	0.00304	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—CCND1—ocular cancer	0.000481	0.003	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.000477	0.00297	CbGpPWpGaD
Teniposide—Stomatitis—Dactinomycin—ocular cancer	0.000466	0.0236	CcSEcCtD
Teniposide—NCOA3—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.000465	0.0029	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000465	0.0029	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—MDM2—ocular cancer	0.000457	0.00285	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—CCND1—ocular cancer	0.000456	0.00284	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—SF3B1—ocular cancer	0.000452	0.00282	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—EP300—ocular cancer	0.000443	0.00276	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CCND3—ocular cancer	0.00044	0.00274	CbGpPWpGaD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—TGFB1—ocular cancer	0.000432	0.00269	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—TFDP1—ocular cancer	0.000427	0.00266	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PSPH—ocular cancer	0.000425	0.00265	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.000424	0.00265	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.000416	0.00259	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.000415	0.00259	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—EP300—ocular cancer	0.000411	0.00256	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.000411	0.00256	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.000408	0.00254	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.000406	0.00253	CbGpPWpGaD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.000404	0.00252	CbGpPWpGaD
Teniposide—Flushing—Dactinomycin—ocular cancer	0.000398	0.0202	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—CCND1—ocular cancer	0.000398	0.00248	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—AKT1—ocular cancer	0.000396	0.00247	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—RB1—ocular cancer	0.000396	0.00247	CbGpPWpGaD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.000395	0.00246	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.000393	0.00245	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.000391	0.00244	CbGpPWpGaD
Teniposide—Chills—Dactinomycin—ocular cancer	0.000385	0.0195	CcSEcCtD
Teniposide—NCOA1—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.000385	0.0024	CbGpPWpGaD
Teniposide—Alopecia—Dactinomycin—ocular cancer	0.000379	0.0192	CcSEcCtD
Teniposide—NCOA3—PPARA activates gene expression—EP300—ocular cancer	0.000374	0.00233	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—EP300—ocular cancer	0.000366	0.00228	CbGpPWpGaD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000366	0.00228	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CCND3—ocular cancer	0.000364	0.00227	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.000362	0.00226	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—TGFB1—ocular cancer	0.000358	0.00223	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.000352	0.00219	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PSPH—ocular cancer	0.000352	0.00219	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.000349	0.00218	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.000349	0.00218	CbGpPWpGaD
Teniposide—Anaemia—Dactinomycin—ocular cancer	0.000345	0.0175	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.000344	0.00215	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.000342	0.00213	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MAML2—ocular cancer	0.000339	0.00211	CbGpPWpGaD
Teniposide—Leukopenia—Dactinomycin—ocular cancer	0.000335	0.017	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.000333	0.00207	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.000323	0.00201	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—EIF1AX—ocular cancer	0.000319	0.00199	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000315	0.00196	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.000313	0.00195	CbGpPWpGaD
Teniposide—NCOA1—PPARA activates gene expression—EP300—ocular cancer	0.000309	0.00193	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.000306	0.00191	CbGpPWpGaD
Teniposide—Oedema—Dactinomycin—ocular cancer	0.000305	0.0155	CcSEcCtD
Teniposide—Infection—Dactinomycin—ocular cancer	0.000303	0.0154	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.000303	0.00189	CbGpPWpGaD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000303	0.00189	CbGpPWpGaD
Teniposide—Thrombocytopenia—Dactinomycin—ocular cancer	0.000299	0.0151	CcSEcCtD
Teniposide—Anorexia—Dactinomycin—ocular cancer	0.000291	0.0147	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00029	0.00181	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.000289	0.0018	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—HRAS—ocular cancer	0.000287	0.00179	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.000287	0.00179	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.000285	0.00177	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—CDKN1A—ocular cancer	0.000284	0.00177	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.000282	0.00176	CbGpPWpGaD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000281	0.00175	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00028	0.00174	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.000279	0.00174	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.000279	0.00174	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.000273	0.0017	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.000273	0.0017	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—AKT1—ocular cancer	0.000268	0.00167	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—E2F5—ocular cancer	0.000265	0.00165	CbGpPWpGaD
Teniposide—Decreased appetite—Dactinomycin—ocular cancer	0.000265	0.0134	CcSEcCtD
Teniposide—NCOA1—Gene Expression—E2F4—ocular cancer	0.00026	0.00162	CbGpPWpGaD
Teniposide—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.000255	0.00159	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—RBL1—ocular cancer	0.000255	0.00159	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—RPL39—ocular cancer	0.000255	0.00159	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—E2F5—ocular cancer	0.000254	0.00159	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—AKT1—ocular cancer	0.000254	0.00158	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.000254	0.00158	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000253	0.00158	CbGpPWpGaD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000252	0.00157	CbGpPWpGaD
Teniposide—Feeling abnormal—Dactinomycin—ocular cancer	0.000251	0.0127	CcSEcCtD
Teniposide—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.000251	0.00156	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000249	0.0126	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—E2F4—ocular cancer	0.000249	0.00155	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.000249	0.00155	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—HDAC1—ocular cancer	0.000248	0.00154	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.000248	0.00154	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.000247	0.00154	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—RBL1—ocular cancer	0.000244	0.00152	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—E2F2—ocular cancer	0.000244	0.00152	CbGpPWpGaD
Teniposide—Body temperature increased—Dactinomycin—ocular cancer	0.000241	0.0122	CcSEcCtD
Teniposide—Abdominal pain—Dactinomycin—ocular cancer	0.000241	0.0122	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000239	0.00149	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.000237	0.00148	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.000237	0.00148	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000237	0.00148	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.000236	0.00147	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—TGFB1—ocular cancer	0.000235	0.00147	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.000234	0.00146	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.000225	0.00141	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.000225	0.0014	CbGpPWpGaD
Teniposide—Hypersensitivity—Dactinomycin—ocular cancer	0.000225	0.0114	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—RBL2—ocular cancer	0.000224	0.0014	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.000222	0.00138	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—AKT1—ocular cancer	0.000221	0.00138	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—RBBP4—ocular cancer	0.000221	0.00138	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00022	0.00137	CbGpPWpGaD
Teniposide—Asthenia—Dactinomycin—ocular cancer	0.000219	0.0111	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000218	0.00136	CbGpPWpGaD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000217	0.00135	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.000215	0.00134	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.000212	0.00132	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—E2F3—ocular cancer	0.000212	0.00132	CbGpPWpGaD
Teniposide—Diarrhoea—Dactinomycin—ocular cancer	0.000209	0.0106	CcSEcCtD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000209	0.0013	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.000208	0.0013	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000208	0.00129	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—TFDP1—ocular cancer	0.000205	0.00128	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.000204	0.00127	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.000202	0.00126	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.0002	0.00125	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.000197	0.00123	CbGpPWpGaD
Teniposide—Vomiting—Dactinomycin—ocular cancer	0.000194	0.00983	CcSEcCtD
Teniposide—Rash—Dactinomycin—ocular cancer	0.000192	0.00975	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—CDK4—ocular cancer	0.000189	0.00118	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000188	0.00117	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000188	0.00117	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000187	0.00117	CbGpPWpGaD
Teniposide—Nausea—Dactinomycin—ocular cancer	0.000181	0.00919	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—CCND3—ocular cancer	0.000179	0.00111	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000177	0.00111	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000175	0.00109	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.000172	0.00107	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.00017	0.00106	CbGpPWpGaD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000166	0.00104	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000166	0.00103	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MAML2—ocular cancer	0.000163	0.00102	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.000158	0.000988	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CDK4—ocular cancer	0.000156	0.000975	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.000151	0.000942	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00015	0.000936	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.000149	0.000928	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.000146	0.000911	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000141	0.000882	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—GNA11—ocular cancer	0.000134	0.000834	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDK6—ocular cancer	0.000133	0.00083	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000131	0.000819	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000128	0.000798	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000128	0.000798	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—GNAQ—ocular cancer	0.000124	0.000776	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000121	0.000756	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00012	0.000748	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—HDAC1—ocular cancer	0.000119	0.000744	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000115	0.000715	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000115	0.000714	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND2—ocular cancer	0.000114	0.000713	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.000114	0.000713	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PSPH—ocular cancer	0.000114	0.000708	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EP300—ocular cancer	0.000112	0.000701	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000111	0.000691	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—GNA11—ocular cancer	0.000111	0.00069	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—CDKN2B—ocular cancer	0.000107	0.000667	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000105	0.000657	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000105	0.000656	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—GNAQ—ocular cancer	0.000103	0.000641	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.000103	0.000639	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.000101	0.000631	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.0001	0.000626	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TGFB1—ocular cancer	9.77e-05	0.000609	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—E2F1—ocular cancer	9.42e-05	0.000587	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EP300—ocular cancer	9.3e-05	0.00058	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	9.18e-05	0.000573	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	9.16e-05	0.000571	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	9.08e-05	0.000566	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	9.08e-05	0.000566	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MYC—ocular cancer	8.61e-05	0.000537	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	8.58e-05	0.000535	CbGpPWpGaD
Teniposide—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	8.33e-05	0.000519	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.3e-05	0.000518	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PSPH—ocular cancer	8.14e-05	0.000507	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDK2—ocular cancer	8.12e-05	0.000506	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TGFB1—ocular cancer	8.08e-05	0.000504	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—ocular cancer	7.69e-05	0.00048	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDK4—ocular cancer	7.68e-05	0.000478	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	7.54e-05	0.00047	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	7.46e-05	0.000465	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—ocular cancer	7.24e-05	0.000451	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—AKT1—ocular cancer	6.79e-05	0.000423	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—RB1—ocular cancer	6.67e-05	0.000416	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	6.37e-05	0.000397	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—ocular cancer	6.36e-05	0.000397	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PSPH—ocular cancer	6.29e-05	0.000392	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	5.81e-05	0.000362	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PSPH—ocular cancer	5.73e-05	0.000357	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MDM2—ocular cancer	5.69e-05	0.000355	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—AKT1—ocular cancer	5.62e-05	0.00035	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	5.54e-05	0.000346	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	5.36e-05	0.000334	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN1B—ocular cancer	5.2e-05	0.000324	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	5.1e-05	0.000318	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CCND1—ocular cancer	4.96e-05	0.000309	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN1A—ocular cancer	4.79e-05	0.000299	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—EP300—ocular cancer	4.56e-05	0.000284	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—EP300—ocular cancer	4.47e-05	0.000279	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	4.45e-05	0.000277	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MYC—ocular cancer	4.14e-05	0.000258	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYC—ocular cancer	3.98e-05	0.000248	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PSPH—ocular cancer	3.78e-05	0.000236	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—EP300—ocular cancer	3.7e-05	0.000231	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GNA11—ocular cancer	3.57e-05	0.000223	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GNAQ—ocular cancer	3.32e-05	0.000207	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—ocular cancer	3.27e-05	0.000204	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—AKT1—ocular cancer	2.87e-05	0.000179	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AKT1—ocular cancer	2.7e-05	0.000168	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GNA11—ocular cancer	2.56e-05	0.00016	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GNAQ—ocular cancer	2.38e-05	0.000148	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKT1—ocular cancer	2.23e-05	0.000139	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GNA11—ocular cancer	1.98e-05	0.000123	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GNAQ—ocular cancer	1.84e-05	0.000115	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GNA11—ocular cancer	1.8e-05	0.000113	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GNAQ—ocular cancer	1.68e-05	0.000105	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.48e-05	9.26e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.35e-05	8.44e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—EP300—ocular cancer	1.19e-05	7.44e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GNA11—ocular cancer	1.19e-05	7.42e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GNAQ—ocular cancer	1.11e-05	6.9e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—EP300—ocular cancer	8.55e-06	5.33e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKT1—ocular cancer	7.21e-06	4.5e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—EP300—ocular cancer	6.61e-06	4.12e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—EP300—ocular cancer	6.03e-06	3.76e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKT1—ocular cancer	5.17e-06	3.22e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKT1—ocular cancer	4e-06	2.49e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—EP300—ocular cancer	3.98e-06	2.48e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKT1—ocular cancer	3.64e-06	2.27e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKT1—ocular cancer	2.4e-06	1.5e-05	CbGpPWpGaD
